{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:02:17Z","timestamp":1779760937186,"version":"3.53.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023QE146"],"award-info":[{"award-number":["ZR2023QE146"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024QH162"],"award-info":[{"award-number":["ZR2024QH162"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023QC179"],"award-info":[{"award-number":["ZR2023QC179"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370618"],"award-info":[{"award-number":["82370618"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302067"],"award-info":[{"award-number":["82302067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160124"],"award-info":[{"award-number":["82160124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114871","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:46:11Z","timestamp":1774583171000},"page":"114871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Manganese-tannic acid immunomodulators potentiate PDGFR\u03b2 CAR-T cell function for additive therapy against liver fibrosis"],"prefix":"10.1016","volume":"394","author":[{"given":"Xinyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianni","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jconrel.2026.114871_bb0005","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114871_bb0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/1061186X.2022.2044485","article-title":"Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review","volume":"30","author":"Zhou","year":"2022","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114871_bb0015","first-page":"60","article-title":"An update on efficacy and safety of emerging hepatic antifibrotic agents","volume":"9","author":"Rupcic Rubin","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114871_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114871_bb0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41467-024-55738-1","article-title":"Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cells","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."},{"issue":"47","key":"10.1016\/j.jconrel.2026.114871_bb0030","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"OPN-mediated crosstalk between hepatocyte E4BP4 and hepatic stellate cells promotes MASH-associated liver fibrosis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)."},{"issue":"19","key":"10.1016\/j.jconrel.2026.114871_bb0035","article-title":"Inflammation-responsive cell membrane-camouflaged nanoparticles against liver fibrosis via regulating endoplasmic reticulum stress and oxidative stress","volume":"36","author":"Bai","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114871_bb0040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ebiom.2019.04.036","article-title":"A PDGFR\u03b2-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease","volume":"43","author":"Lambrecht","year":"2019","journal-title":"EBioMedicine"},{"issue":"7971","key":"10.1016\/j.jconrel.2026.114871_bb0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","article-title":"CAR T therapy beyond cancer: the evolution of a living drug","volume":"619","author":"Baker","year":"2023","journal-title":"Nature"},{"issue":"7814","key":"10.1016\/j.jconrel.2026.114871_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114871_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103941","article-title":"Improving CAR-T immunotherapy: overcoming the challenges of T cell exhaustion","volume":"77","author":"Gumber","year":"2022","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114871_bb0060","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"37","key":"10.1016\/j.jconrel.2026.114871_bb0065","doi-asserted-by":"crossref","first-page":"33212","DOI":"10.1021\/acsnano.5c07601","article-title":"Tannic acid-Iron complex-based nanozyme ameliorates Parkinson\u2019s disease via relieving oxidative stress and neuroinflammation","volume":"19","author":"He","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114871_bb0070","article-title":"Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma","volume":"11(18):eads8597","author":"Qu","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114871_bb0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s43556-023-00122-6","article-title":"Gallic acid enhances anti-lymphoma function of anti-CD19 CAR-T cells in vitro and in vivo","volume":"4","author":"Luo","year":"2023","journal-title":"Mol Biomed."},{"issue":"24","key":"10.1016\/j.jconrel.2026.114871_bb0080","article-title":"Spherical nucleic acids-directed Cryosynthesis of manganese Nanoagents for tumor imaging and therapy","volume":"64","author":"Xie","year":"2025","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114871_bb0085","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.stem.2025.07.014","article-title":"Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease","volume":"32","author":"Zhao","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114871_bb0090","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2026.114871_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Asp. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114871_bb0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jphs.2015.12.002","article-title":"Ameliorative effects of tannic acid on carbon tetrachloride-induced liver fibrosis in vivo and in vitro","volume":"130","author":"Chu","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.114871_bb0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2023.01.052","article-title":"Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells","volume":"355","author":"Xia","year":"2023","journal-title":"J. Control. Release"},{"issue":"15","key":"10.1016\/j.jconrel.2026.114871_bb0110","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1021\/acsnano.3c03217","article-title":"Nanoparticle-mediated RNA therapy attenuates nonalcoholic steatohepatitis and related fibrosis by targeting activated hepatic stellate cells","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114871_bb0115","first-page":"78","article-title":"Critical care management of chimeric antigen receptor T-cell therapy recipients","volume":"72","author":"Shimabukuro-Vornhagen","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114871_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","article-title":"Overcoming on-target, off-tumor toxicity of CAR T cell therapy for solid tumors","volume":"20","author":"Flugel","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114871_bb0125","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.ymthe.2025.01.012","article-title":"The high efficacy of claudin18.2-targeted CAR-T cell therapy in advanced pancreatic cancer with an antibody-dependent safety strategy","volume":"33","author":"Zhong","year":"2025","journal-title":"Mol. Ther."},{"issue":"7783","key":"10.1016\/j.jconrel.2026.114871_bb0130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114871_bb0135","doi-asserted-by":"crossref","first-page":"44544","DOI":"10.1038\/srep44544","article-title":"Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-\u03b2-dependent emperipolesis in HBV cirrhotic patients","volume":"7","author":"Shi","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114871_bb0140","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","article-title":"Liver macrophages in health and disease","volume":"55","author":"Guilliams","year":"2022","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114871_bb0145","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114871_bb0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mam.2018.06.003","article-title":"Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications","volume":"65","author":"Weiskirchen","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jconrel.2026.114871_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154349","article-title":"Demethylzeylasteral attenuates hepatic stellate cell activation and liver fibrosis by inhibiting AGAP2 mediated signaling","volume":"105","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jconrel.2026.114871_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157108","article-title":"Alpha-tocopheryl quinone attenuates liver fibrosis through enriching Christensenella minuta and modulating bile acids metabolism via gut-liver axis","volume":"146","author":"Chen","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114871_bb0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-024-01631-9","article-title":"RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms","volume":"17","author":"Yang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114871_bb0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gendis.2022.05.006","article-title":"Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: current status in clinical trials","volume":"10","author":"Song","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.jconrel.2026.114871_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115842","article-title":"Unraveling the interplay between RAS\/RAF\/MEK\/ERK signaling pathway and autophagy in cancer: from molecular mechanisms to targeted therapy","volume":"217","author":"Huang","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114871_bb0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114871_bb0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-biochem-052521-040754","article-title":"Signaling from RAS to RAF: the molecules and their mechanisms","volume":"93","author":"Jeon","year":"2024","journal-title":"Annu. Rev. Biochem."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114871_bb0190","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41577-024-01040-6","article-title":"A guide to adaptive immune memory","volume":"24","author":"Lam","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114871_bb0195","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007803","article-title":"CD8+ chimeric antigen receptor T cells manufactured in absence of CD4+ cells exhibit hypofunctional phenotype","volume":"11","author":"Lee","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114871_bb0200","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114871_bb0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/pharmaceutics17030303","article-title":"A quantitative approach to potency testing for chimeric antigen receptor-encoding lentiviral vectors and autologous CAR-T cell products, using flow cytometry","volume":"17","author":"Mata-Molanes","year":"2025","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114871_bb0210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2024.01.011","article-title":"Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks","volume":"57","author":"Jaeger-Ruckstuhl","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114871_bb0215","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12916-021-02085-3","article-title":"HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis","volume":"19","author":"Xie","year":"2021","journal-title":"BMC Med."},{"issue":"Pt 2","key":"10.1016\/j.jconrel.2026.114871_bb0220","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.freeradbiomed.2022.10.322","article-title":"FNDC3B protects steatosis and ferroptosis via the AMPK pathway in alcoholic fatty liver disease","volume":"193","author":"You","year":"2022","journal-title":"Free Radic. Biol. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:03:42Z","timestamp":1779757422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926002737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S0168365926002737"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114871","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manganese-tannic acid immunomodulators potentiate PDGFR\u03b2 CAR-T cell function for additive therapy against liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114871"}}